 Srikant Ramaswami |
Srikant (Sri) Ramaswami, executive VP/healthcare at rbb Communications, has joined Caris Life Sciences as VP-chief communications officer.
Prior to rbb, the 20-year pharma PR veteran worked at Merck, Pfizer and Johnson & Johnson.
At J&J, he spearheaded its pharmaceuticals effort in China and then served as VP/Asia-Pacific in the medical devices group.
Irving, TX-based CLS' molecular profiling offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps doctors/cancer patients make more precise and personalized treatment decisions.
CLS relies on The Ruth Group for media relations work.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
